6S55
Crystal structure of human ATAD2 bromodomain in complex with N-(4-bromo-3-((3-methylpiperidin-1-yl)sulfonyl)phenyl)-2-(2,5-dioxoimidazolidin-1-yl)acetamide
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | ROTATING ANODE |
Source details | RIGAKU FR-E+ SUPERBRIGHT |
Temperature [K] | 100 |
Detector technology | CCD |
Collection date | 2013-08-30 |
Detector | RIGAKU |
Wavelength(s) | 1.547 |
Spacegroup name | P 65 2 2 |
Unit cell lengths | 79.664, 79.664, 137.341 |
Unit cell angles | 90.00, 90.00, 120.00 |
Refinement procedure
Resolution | 48.670 - 2.090 |
R-factor | 0.18644 |
Rwork | 0.184 |
R-free | 0.24328 |
Structure solution method | FOURIER SYNTHESIS |
RMSD bond length | 0.008 |
RMSD bond angle | 1.421 |
Data reduction software | XDS |
Data scaling software | SCALA |
Refinement software | REFMAC (5.8.0238) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 137.340 | 2.200 |
High resolution limit [Å] | 2.090 | 2.090 |
Number of reflections | 15970 | 2247 |
<I/σ(I)> | 19.3 | |
Completeness [%] | 99.8 | |
Redundancy | 10.7 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, SITTING DROP | 278 | 0.1M trisHCl pH 7.0-8.0, 1.2-1.5M ammonium sulphate and 20-25% PEG3350 |